カテゴリー： Market Monitor Global, 世界, 医療/バイオ

カルメット菌ゲリン菌ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Bacillus Calmette Guerin Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5706）

◆商品コード：MMG23JU5706
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Bacillus Calmette Guerin Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのカルメット菌ゲリン菌ワクチン市場規模と予測を収録しています。・世界のカルメット菌ゲリン菌ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のカルメット菌ゲリン菌ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のカルメット菌ゲリン菌ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫用」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

カルメット菌ゲリン菌ワクチンのグローバル主要企業は、Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVACなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、カルメット菌ゲリン菌ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のカルメット菌ゲリン菌ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のカルメット菌ゲリン菌ワクチン市場：タイプ別市場シェア、2022年
・免疫用、治療用

世界のカルメット菌ゲリン菌ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のカルメット菌ゲリン菌ワクチン市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のカルメット菌ゲリン菌ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のカルメット菌ゲリン菌ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル売上、2018年-2023年
・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル売上シェア、2022年
・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるカルメット菌ゲリン菌ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC

*************************************************************

・調査・分析レポートの概要
カルメット菌ゲリン菌ワクチン市場の定義
市場セグメント
世界のカルメット菌ゲリン菌ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のカルメット菌ゲリン菌ワクチン市場規模
世界のカルメット菌ゲリン菌ワクチン市場規模：2022年 VS 2029年
世界のカルメット菌ゲリン菌ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのカルメット菌ゲリン菌ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のカルメット菌ゲリン菌ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫用、治療用
カルメット菌ゲリン菌ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
カルメット菌ゲリン菌ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別カルメット菌ゲリン菌ワクチン市場規模 2022年と2029年
地域別カルメット菌ゲリン菌ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 AJ Vaccines、 Serum Institute of India、 Intervax、 GSBPL、 Statens Serum Institute、 Biomed Lublin、 ANLIS Malbran、 Fundação Ataulpho de Paiva、 BB-NCIPD、 Taj Pharmaceuticals、 Bio Farma、 Microgen、 Torlakinstitut、 Institut Pasteur de Tunis、 IVAC
...

Bacillus Calmette Guerin Vaccine provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
This report aims to provide a comprehensive presentation of the global market for Bacillus Calmette Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacillus Calmette Guerin Vaccine. This report contains market size and forecasts of Bacillus Calmette Guerin Vaccine in global, including the following market information:
Global Bacillus Calmette Guerin Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bacillus Calmette Guerin Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Bacillus Calmette Guerin Vaccine companies in 2022 (%)
The global Bacillus Calmette Guerin Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bacillus Calmette Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacillus Calmette Guerin Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacillus Calmette Guerin Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, by Type, 2022 (%)
Immune Type
Therapy Type
Global Bacillus Calmette Guerin Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Bacillus Calmette Guerin Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Bacillus Calmette Guerin Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacillus Calmette Guerin Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bacillus Calmette Guerin Vaccine revenues share in global market, 2022 (%)
Key companies Bacillus Calmette Guerin Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Bacillus Calmette Guerin Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bacillus Calmette Guerin Vaccine, market overview.
Chapter 2: Global Bacillus Calmette Guerin Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Bacillus Calmette Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacillus Calmette Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bacillus Calmette Guerin Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Bacillus Calmette Guerin Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bacillus Calmette Guerin Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bacillus Calmette Guerin Vaccine Overall Market Size
2.1 Global Bacillus Calmette Guerin Vaccine Market Size: 2022 VS 2029
2.2 Global Bacillus Calmette Guerin Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bacillus Calmette Guerin Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Bacillus Calmette Guerin Vaccine Players in Global Market
3.2 Top Global Bacillus Calmette Guerin Vaccine Companies Ranked by Revenue
3.3 Global Bacillus Calmette Guerin Vaccine Revenue by Companies
3.4 Global Bacillus Calmette Guerin Vaccine Sales by Companies
3.5 Global Bacillus Calmette Guerin Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bacillus Calmette Guerin Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bacillus Calmette Guerin Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bacillus Calmette Guerin Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Bacillus Calmette Guerin Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Bacillus Calmette Guerin Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bacillus Calmette Guerin Vaccine Market Size Markets, 2022 & 2029
4.1.2 Immune Type
4.1.3 Therapy Type
4.2 By Type – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
4.2.1 By Type – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
4.3.1 By Type – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
4.3.2 By Type – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
4.3.3 By Type – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Bacillus Calmette Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bacillus Calmette Guerin Vaccine Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
5.2.1 By Application – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
5.3.1 By Application – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
5.3.2 By Application – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
5.3.3 By Application – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Bacillus Calmette Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bacillus Calmette Guerin Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Bacillus Calmette Guerin Vaccine Revenue & Forecasts
6.2.1 By Region – Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Bacillus Calmette Guerin Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Bacillus Calmette Guerin Vaccine Sales & Forecasts
6.3.1 By Region – Global Bacillus Calmette Guerin Vaccine Sales, 2018-2023
6.3.2 By Region – Global Bacillus Calmette Guerin Vaccine Sales, 2024-2029
6.3.3 By Region – Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.4.3 US Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.4.4 Canada Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.4.5 Mexico Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.5.3 Germany Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.4 France Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.5 U.K. Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.6 Italy Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.7 Russia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.5.9 Benelux Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.6.3 China Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.4 Japan Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.5 South Korea Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.6.7 India Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.7.3 Brazil Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.7.4 Argentina Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bacillus Calmette Guerin Vaccine Sales, 2018-2029
6.8.3 Turkey Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.4 Israel Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
6.8.6 UAE Bacillus Calmette Guerin Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Bacillus Calmette Guerin Vaccine Major Product Offerings
7.1.4 Merck Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Major Product Offerings
7.2.4 Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab Bacillus Calmette Guerin Vaccine Major Product Offerings
7.3.4 Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Lab Key News & Latest Developments
7.4 China National Biotec
7.4.1 China National Biotec Company Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec Bacillus Calmette Guerin Vaccine Major Product Offerings
7.4.4 China National Biotec Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Key News & Latest Developments
7.5 AJ Vaccines
7.5.1 AJ Vaccines Company Summary
7.5.2 AJ Vaccines Business Overview
7.5.3 AJ Vaccines Bacillus Calmette Guerin Vaccine Major Product Offerings
7.5.4 AJ Vaccines Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 AJ Vaccines Key News & Latest Developments
7.6 Serum Institute of India
7.6.1 Serum Institute of India Company Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India Bacillus Calmette Guerin Vaccine Major Product Offerings
7.6.4 Serum Institute of India Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Key News & Latest Developments
7.7 Intervax
7.7.1 Intervax Company Summary
7.7.2 Intervax Business Overview
7.7.3 Intervax Bacillus Calmette Guerin Vaccine Major Product Offerings
7.7.4 Intervax Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Intervax Key News & Latest Developments
7.8 GSBPL
7.8.1 GSBPL Company Summary
7.8.2 GSBPL Business Overview
7.8.3 GSBPL Bacillus Calmette Guerin Vaccine Major Product Offerings
7.8.4 GSBPL Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 GSBPL Key News & Latest Developments
7.9 Statens Serum Institute
7.9.1 Statens Serum Institute Company Summary
7.9.2 Statens Serum Institute Business Overview
7.9.3 Statens Serum Institute Bacillus Calmette Guerin Vaccine Major Product Offerings
7.9.4 Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Statens Serum Institute Key News & Latest Developments
7.10 Biomed Lublin
7.10.1 Biomed Lublin Company Summary
7.10.2 Biomed Lublin Business Overview
7.10.3 Biomed Lublin Bacillus Calmette Guerin Vaccine Major Product Offerings
7.10.4 Biomed Lublin Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Biomed Lublin Key News & Latest Developments
7.11 ANLIS Malbran
7.11.1 ANLIS Malbran Company Summary
7.11.2 ANLIS Malbran Bacillus Calmette Guerin Vaccine Business Overview
7.11.3 ANLIS Malbran Bacillus Calmette Guerin Vaccine Major Product Offerings
7.11.4 ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 ANLIS Malbran Key News & Latest Developments
7.12 Fundação Ataulpho de Paiva
7.12.1 Fundação Ataulpho de Paiva Company Summary
7.12.2 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Business Overview
7.12.3 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Major Product Offerings
7.12.4 Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Fundação Ataulpho de Paiva Key News & Latest Developments
7.13 BB-NCIPD
7.13.1 BB-NCIPD Company Summary
7.13.2 BB-NCIPD Bacillus Calmette Guerin Vaccine Business Overview
7.13.3 BB-NCIPD Bacillus Calmette Guerin Vaccine Major Product Offerings
7.13.4 BB-NCIPD Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 BB-NCIPD Key News & Latest Developments
7.14 Taj Pharmaceuticals
7.14.1 Taj Pharmaceuticals Company Summary
7.14.2 Taj Pharmaceuticals Business Overview
7.14.3 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Major Product Offerings
7.14.4 Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Taj Pharmaceuticals Key News & Latest Developments
7.15 Bio Farma
7.15.1 Bio Farma Company Summary
7.15.2 Bio Farma Business Overview
7.15.3 Bio Farma Bacillus Calmette Guerin Vaccine Major Product Offerings
7.15.4 Bio Farma Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Bio Farma Key News & Latest Developments
7.16 Microgen
7.16.1 Microgen Company Summary
7.16.2 Microgen Business Overview
7.16.3 Microgen Bacillus Calmette Guerin Vaccine Major Product Offerings
7.16.4 Microgen Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Microgen Key News & Latest Developments
7.17 Torlakinstitut
7.17.1 Torlakinstitut Company Summary
7.17.2 Torlakinstitut Business Overview
7.17.3 Torlakinstitut Bacillus Calmette Guerin Vaccine Major Product Offerings
7.17.4 Torlakinstitut Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Torlakinstitut Key News & Latest Developments
7.18 Institut Pasteur de Tunis
7.18.1 Institut Pasteur de Tunis Company Summary
7.18.2 Institut Pasteur de Tunis Business Overview
7.18.3 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Major Product Offerings
7.18.4 Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Institut Pasteur de Tunis Key News & Latest Developments
7.19 IVAC
7.19.1 IVAC Company Summary
7.19.2 IVAC Business Overview
7.19.3 IVAC Bacillus Calmette Guerin Vaccine Major Product Offerings
7.19.4 IVAC Bacillus Calmette Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 IVAC Key News & Latest Developments
8 Global Bacillus Calmette Guerin Vaccine Production Capacity, Analysis
8.1 Global Bacillus Calmette Guerin Vaccine Production Capacity, 2018-2029
8.2 Bacillus Calmette Guerin Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Bacillus Calmette Guerin Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bacillus Calmette Guerin Vaccine Supply Chain Analysis
10.1 Bacillus Calmette Guerin Vaccine Industry Value Chain
10.2 Bacillus Calmette Guerin Vaccine Upstream Market
10.3 Bacillus Calmette Guerin Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bacillus Calmette Guerin Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Bacillus Calmette Guerin Vaccine in Global Market
Table 2. Top Bacillus Calmette Guerin Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Bacillus Calmette Guerin Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Bacillus Calmette Guerin Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Bacillus Calmette Guerin Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Bacillus Calmette Guerin Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Bacillus Calmette Guerin Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Bacillus Calmette Guerin Vaccine Product Type
Table 9. List of Global Tier 1 Bacillus Calmette Guerin Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bacillus Calmette Guerin Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Bacillus Calmette Guerin Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Bacillus Calmette Guerin Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Bacillus Calmette Guerin Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Bacillus Calmette Guerin Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Bacillus Calmette Guerin Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Bacillus Calmette Guerin Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Bacillus Calmette Guerin Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Bacillus Calmette Guerin Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Bacillus Calmette Guerin Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Bacillus Calmette Guerin Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Sales, (K Units), 2024-2029
Table 46. Merck Company Summary
Table 47. Merck Bacillus Calmette Guerin Vaccine Product Offerings
Table 48. Merck Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. Sanofi Pasteur Company Summary
Table 51. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Product Offerings
Table 52. Sanofi Pasteur Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sanofi Pasteur Key News & Latest Developments
Table 54. Japan BCG Lab Company Summary
Table 55. Japan BCG Lab Bacillus Calmette Guerin Vaccine Product Offerings
Table 56. Japan BCG Lab Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Japan BCG Lab Key News & Latest Developments
Table 58. China National Biotec Company Summary
Table 59. China National Biotec Bacillus Calmette Guerin Vaccine Product Offerings
Table 60. China National Biotec Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. China National Biotec Key News & Latest Developments
Table 62. AJ Vaccines Company Summary
Table 63. AJ Vaccines Bacillus Calmette Guerin Vaccine Product Offerings
Table 64. AJ Vaccines Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AJ Vaccines Key News & Latest Developments
Table 66. Serum Institute of India Company Summary
Table 67. Serum Institute of India Bacillus Calmette Guerin Vaccine Product Offerings
Table 68. Serum Institute of India Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Serum Institute of India Key News & Latest Developments
Table 70. Intervax Company Summary
Table 71. Intervax Bacillus Calmette Guerin Vaccine Product Offerings
Table 72. Intervax Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Intervax Key News & Latest Developments
Table 74. GSBPL Company Summary
Table 75. GSBPL Bacillus Calmette Guerin Vaccine Product Offerings
Table 76. GSBPL Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. GSBPL Key News & Latest Developments
Table 78. Statens Serum Institute Company Summary
Table 79. Statens Serum Institute Bacillus Calmette Guerin Vaccine Product Offerings
Table 80. Statens Serum Institute Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Statens Serum Institute Key News & Latest Developments
Table 82. Biomed Lublin Company Summary
Table 83. Biomed Lublin Bacillus Calmette Guerin Vaccine Product Offerings
Table 84. Biomed Lublin Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Biomed Lublin Key News & Latest Developments
Table 86. ANLIS Malbran Company Summary
Table 87. ANLIS Malbran Bacillus Calmette Guerin Vaccine Product Offerings
Table 88. ANLIS Malbran Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. ANLIS Malbran Key News & Latest Developments
Table 90. Fundação Ataulpho de Paiva Company Summary
Table 91. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Product Offerings
Table 92. Fundação Ataulpho de Paiva Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Fundação Ataulpho de Paiva Key News & Latest Developments
Table 94. BB-NCIPD Company Summary
Table 95. BB-NCIPD Bacillus Calmette Guerin Vaccine Product Offerings
Table 96. BB-NCIPD Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. BB-NCIPD Key News & Latest Developments
Table 98. Taj Pharmaceuticals Company Summary
Table 99. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Product Offerings
Table 100. Taj Pharmaceuticals Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Taj Pharmaceuticals Key News & Latest Developments
Table 102. Bio Farma Company Summary
Table 103. Bio Farma Bacillus Calmette Guerin Vaccine Product Offerings
Table 104. Bio Farma Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Bio Farma Key News & Latest Developments
Table 106. Microgen Company Summary
Table 107. Microgen Bacillus Calmette Guerin Vaccine Product Offerings
Table 108. Microgen Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Microgen Key News & Latest Developments
Table 110. Torlakinstitut Company Summary
Table 111. Torlakinstitut Bacillus Calmette Guerin Vaccine Product Offerings
Table 112. Torlakinstitut Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Torlakinstitut Key News & Latest Developments
Table 114. Institut Pasteur de Tunis Company Summary
Table 115. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Product Offerings
Table 116. Institut Pasteur de Tunis Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Institut Pasteur de Tunis Key News & Latest Developments
Table 118. IVAC Company Summary
Table 119. IVAC Bacillus Calmette Guerin Vaccine Product Offerings
Table 120. IVAC Bacillus Calmette Guerin Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. IVAC Key News & Latest Developments
Table 122. Bacillus Calmette Guerin Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Bacillus Calmette Guerin Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Bacillus Calmette Guerin Vaccine Production by Region, 2018-2023 (K Units)
Table 125. Global Bacillus Calmette Guerin Vaccine Production by Region, 2024-2029 (K Units)
Table 126. Bacillus Calmette Guerin Vaccine Market Opportunities & Trends in Global Market
Table 127. Bacillus Calmette Guerin Vaccine Market Drivers in Global Market
Table 128. Bacillus Calmette Guerin Vaccine Market Restraints in Global Market
Table 129. Bacillus Calmette Guerin Vaccine Raw Materials
Table 130. Bacillus Calmette Guerin Vaccine Raw Materials Suppliers in Global Market
Table 131. Typical Bacillus Calmette Guerin Vaccine Downstream
Table 132. Bacillus Calmette Guerin Vaccine Downstream Clients in Global Market
Table 133. Bacillus Calmette Guerin Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bacillus Calmette Guerin Vaccine Segment by Type in 2022
Figure 2. Bacillus Calmette Guerin Vaccine Segment by Application in 2022
Figure 3. Global Bacillus Calmette Guerin Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bacillus Calmette Guerin Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bacillus Calmette Guerin Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Bacillus Calmette Guerin Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bacillus Calmette Guerin Vaccine Revenue in 2022
Figure 9. By Type - Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Bacillus Calmette Guerin Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Bacillus Calmette Guerin Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 23. US Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 37. China Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Bacillus Calmette Guerin Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Bacillus Calmette Guerin Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Bacillus Calmette Guerin Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Bacillus Calmette Guerin Vaccine by Region, 2022 VS 2029
Figure 54. Bacillus Calmette Guerin Vaccine Industry Value Chain
Figure 55. Marketing Channels

※参考情報

カルメット菌ゲリン菌ワクチン（BCGワクチン）は、結核予防のために使用されるワクチンであり、その歴史は20世紀初頭に遡ります。このワクチンは、フランスのバクテリア学者アルベール・カルメットとコクシーの研究者であるカミーユ・ゲリンによって開発されました。彼らは、結核菌を弱毒化し、その特性を利用して免疫を促進するワクチンの開発に成功しました。BCGワクチンは、世界中で広く使用されており、多くの国で結核の予防接種として推奨されています。

BCGワクチンの特徴として、その成分である弱毒化された結核菌が挙げられます。この菌は、病気を引き起こすことはありませんが、免疫系を刺激し、体内に抗体を生成することで、実際の結核菌に対する防御を強化します。通常、BCGワクチンは生後数ヶ月以内に接種されることが推奨されており、特に結核の流行が見られる地域では重要な公衆衛生対策として位置づけられています。

BCGワクチンにはいくつかの種類が存在しますが、最も広く使用されているのは、フランスのパリで開発されたStrain（株）であるBCG Tokyoです。この株は、1939年から使用されており、日本国内での接種も広く行われています。BCGワクチンは、他のワクチンと比べて比較的副作用が少ないとされており、接種後の腫れや痛み、発熱などの軽度な反応は一般的です。

BCGワクチンの主な用途は、結核の予防です。特に、乳幼児に対する結核の重篤な形態である粟粒結核（粟粒性結核）の予防に効果があります。結核は世界的な公衆衛生問題であり、毎年多くの人々が感染し、死亡に至っています。BCGワクチンの接種によって、多くの国で結核の発生率が低下しているさまざまなエビデンスが存在しています。また、BCGワクチンは、他の関連疾患に対する免疫応答を向上させる可能性があることも研究されています。例えば、BCGワクチンは、特定の癌の治療や予防に関しても注目されており、膀胱癌の治療にはBCG療法が用いられることがあります。

さらに、BCGワクチンは、近年の研究により、自己免疫疾患やアレルギーの予防への可能性についても探求されています。BCGの免疫応答が、体内の炎症反応を調節し、非特異的な免疫を強化することで、さまざまな病気に対する防御を向上させる可能性があるとされています。そのため、BCGワクチンは結核予防としてだけでなく、他の疾患に対する治療や予防の手段としてもサポートされています。

BCGワクチンの製造に関連する技術も進化しており、品質管理や製造プロセスの改善が進められています。特に、ワクチン接種に伴う副作用を最小限に抑えつつ、高い効果を維持するための技術が求められています。また、BCGワクチンの安定性を向上させるための冷凍保存技術や、ワクチンの効果を最大限に引き出すためのアジュバント（免疫応答を強化する添加物）の研究も進行しています。

現在、BCGワクチンは、全世界的に使用されていますが、その効果や安全性については今なお研究が続けられています。一部の地域では、BCGワクチンの効果が見られない場合や、さらなる研究が必要とされる状況も存在します。特に、新たな結核菌の変異株や薬剤耐性を持つ結核の増加に対応するための新しいワクチンの開発も急務です。

BCGワクチンの有効性や安全性についての研究結果は、その使用とともに評価されており、今後のワクチン研究や公衆衛生政策への影響が期待されています。また、BCGワクチンは、基礎研究から臨床応用まで幅広い分野での学術的なアプローチを必要とし、さまざまな疾患に対する防御のメカニズムを解明することが求められています。

結局のところ、カルメット菌ゲリン菌ワクチンは、結核予防のために不可欠な生物製剤としての地位を確立してきました。過去の実績から学びながら、新たな知識と技術の進展を通じて、今後もその役割が強調されていくことが期待されています。BCGワクチンのさらなる研究開発が進むことにより、新しい予防策や治療法が生まれることが期待しており、無病社会の実現に向けた努力が続けられています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ カルメット菌ゲリン菌ワクチンの世界市場見通し2023年-2029年(Bacillus Calmette Guerin Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

カルメット菌ゲリン菌ワクチンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp